Systems-wide analysis of histone lysine 2-hydroxyisobutyrylation pathway
Systems-wide analysis of histone lysine 2-hydroxyisobutyrylation pathway
批准号:
9458207
负责人:
YINGMING ZHAO
金额:
$44.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-20 至 2020-03-31
关键词:
AreaBindingBinding ProteinsBiochemicalBiochemistryBiologicalBiological AssayBiological ModelsBiological ProcessBiologyCardiovascular DiseasesCardiovascular systemCell Cycle StageCell Differentiation processCell ExtractsCell physiologyCellsChIP-seqChromatinChromatin StructureCoenzyme ADataData SetDevelopmentDiabetes MellitusDiseaseDrug TargetingEnzymesEpigenetic ProcessExperimental ModelsFractionationGene ExpressionGene Expression RegulationGenetic TranscriptionGenomicsGerm CellsHistone AcetylationHistonesHumanImmune System DiseasesIn VitroKnowledgeLysineMalignant NeoplasmsMass Spectrum AnalysisMediatingMeiosisMethylationMolecularMusN-terminalPathway interactionsPeptide LibraryPeptidesPositioning AttributePost-Translational Protein ProcessingProcessProteinsProteomicsReaderRecombinantsRegulatory ElementReportingResearchRoleSiteSpermatogenic CellSystemSystems BiologyTestingTetrahymenaTissuesUniversitiesWorkbasecell typeembryonic stem cellepigenomeepigenomicsexperimental studyhistone methylationhistone modificationhistone-binding proteinshuman diseaseimprovedin vitro activityin vivomalemouse genomenerve stem cellnervous system disordernovelprotein complexpublic health relevancereconstitutionsperm cellstem cell biologystem cell differentiationstoichiometrysuccessthermophilic organismtranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Histone post-translational modification (PTM, or histone mark) is critical to dynamic modulation of chromatin structure and function. Dysregulation of histone modification processes contributes to the development of many diseases, such as cancer, cardiovascular and neurological diseases. We recently reported a new, evolutionarily-conserved histone mark, lysine 2-hydroxyisobutyrylation (Khib). We showed that Khib is present among 63 histone lysine residues in both human and mouse, more than the known numbers of the widely studied histone acetylation (Kac) and methylation (Kme) sites. We also obtained multiple lines of evidence that suggest important and unique biological functions of histone Khib: this class of histone modification shows distinct genomic distributions from the widely studied histone Kac during male germ cell differentiation; it is associated with active gene
transcription and H4K8hib is a better indicator for high gene expression than its corresponding H4K8ac; histone Khib can direct in vitro transcription in a manner dependent on 2-hydroxyisobutyryl CoA, suggesting that histone Khib impacts chromatin structure and transcriptional activity; histone Khib has different profiles between transcriptionally active and transcriptionally silent chromatin in Tetrahymena thermophile, in different cell cycle stages, and during mouse spermotogenesis. These results suggest that histone Khib is structurally and mechanistically different from histone Kac. The major players regulating histone Khib pathway would break new ground in epigenetic research and improve our understanding of cellular physiology and human disease. In the proposed research, we will study histone Khib pathway using an integrated approach. We will identify histone Khib-regulatory enzymes and direct binding proteins of histone Khib marks. We will also investigate genomic distributions of key histone Khib marks in mouse genome, and compare these data with those of the well-studied histone acetylation and methylation marks. Our team is well positioned to carry out this project, because of our extensive expertise in the areas of epigenomics, biochemistry, proteomics, stem cell biology, and the tremendous preliminary results we generated. This study will overcome a major hurdle to study biology of histone Khib pathway by revealing key regulatory elements and likely characterize novel epigenetic mechanisms, perhaps analogous to the characterization of histone Kac and Kme pathways.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Systematic screening for new histone marks and studying their epigenetic function
-
批准号:10579280
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2020
-
负责人:YINGMING ZHAO
-
依托单位:
Systematic screening for new histone marks and studying their epigenetic function
-
批准号:10401345
-
项目类别:
-
资助金额:$50.89万
-
财政年份:2020
-
负责人:YINGMING ZHAO
-
依托单位:
Biochemistry of lysine crotonylation pathway
-
批准号:8482624
-
项目类别:
-
资助金额:$43.66万
-
财政年份:2013
-
负责人:YINGMING ZHAO
-
依托单位:
Biochemistry of lysine crotonylation pathway
-
批准号:8654351
-
项目类别:
-
资助金额:$42.37万
-
财政年份:2013
-
负责人:YINGMING ZHAO
-
依托单位:
APPLICATION OF PTMAP2 FOR PROTEIN POSTTRANSLATIONAL MODIFICATION ANALYSIS
-
批准号:8364316
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2011
-
负责人:YINGMING ZHAO
-
依托单位:
APPLICATION OF PTMAP2 FOR PROTEIN POSTTRANSLATIONAL MODIFICATION ANALYSIS
-
批准号:8171932
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2010
-
负责人:YINGMING ZHAO
-
依托单位:
DEVELOPMENT OF PTMAP20 FOR GENOME-WIDE PROTEIN POSTTRANSLATIONAL MODIFICATION
-
批准号:8171905
-
项目类别:
-
资助金额:$0.14万
-
财政年份:2010
-
负责人:YINGMING ZHAO
-
依托单位:
DEVELOPMENT OF PTMAP20 FOR GENOME-WIDE PROTEIN POSTTRANSLATIONAL MODIFICATION
-
批准号:7956366
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2009
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:7817093
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Systematic screening for new histone marks
-
批准号:7693723
-
项目类别:
-
资助金额:$77.65万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:8069184
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:7567516
-
项目类别:
-
资助金额:$32.37万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:8250391
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:7372721
-
项目类别:
-
资助金额:$6.47万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Global characterization of lysine acetylation in cancer by a proteomics approach
-
批准号:7741585
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
Systematic screening for new histone marks
-
批准号:7910580
-
项目类别:
-
资助金额:$76.87万
-
财政年份:2008
-
负责人:YINGMING ZHAO
-
依托单位:
A Novel Proteomics Technology for Protein Farnesylation
-
批准号:7194502
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2004
-
负责人:YINGMING ZHAO
-
依托单位:
A Novel Proteomics Technology for Protein Farnesylation
-
批准号:6785160
-
项目类别:
-
资助金额:$14.04万
-
财政年份:2004
-
负责人:YINGMING ZHAO
-
依托单位:
A Novel Proteomics Technology for Protein Farnesylation
-
批准号:7383094
-
项目类别:
-
资助金额:$4.93万
-
财政年份:2004
-
负责人:YINGMING ZHAO
-
依托单位:
A Novel Proteomics Technology for Protein Farnesylation
-
批准号:7220601
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2004
-
负责人:YINGMING ZHAO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: